21 Aug

New product with templates.

Lipum’s drug candidate SOL-116 is a humanized antibody expected to offer a unique mechanism of action for treatment of chronic inflammatory diseases such as rheumatoid arthritis (RA). Our goal is for SOL-116 to alleviate painful symptoms and improve the quality of life for the millions of patients suffering from chronic inflammatory diseases.